Biologics and Biosimilars Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4096459
- 127 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Biologics and Biosimilars market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Biologics and Biosimilars market segmented into
Packing Industry
PHA
Bio-PE
Starch Blends
PLA
Others
Based on the end-use, the global Biologics and Biosimilars market classified into
Packing Industry
Automotive Industry
Bottles manufacturing
Others
Based on geography, the global Biologics and Biosimilars market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
NatureWorks
Braskem
BASF
Arkema
DuPont
Novamont
Corbion
Metabolix
PSM
PolyOne
Biome Bioplastics
Biomer
FKuR
Trellis Bioplastics
Kingfa
Cardia Bioplastics
Grabio
MHG
Myriant
Mitsubishi
Zhejiang Hisun Biomaterials
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOLOGICS AND BIOSIMILARS INDUSTRY
2.1 Summary about Biologics and Biosimilars Industry
2.2 Biologics and Biosimilars Market Trends
2.2.1 Biologics and Biosimilars Production & Consumption Trends
2.2.2 Biologics and Biosimilars Demand Structure Trends
2.3 Biologics and Biosimilars Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Bio-PET
4.2.2 PHA
4.2.3 Bio-PE
4.2.4 Starch Blends
4.2.5 PLA
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Packing Industry
4.3.2 Automotive Industry
4.3.3 Bottles manufacturing
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Bio-PET
5.2.2 PHA
5.2.3 Bio-PE
5.2.4 Starch Blends
5.2.5 PLA
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Packing Industry
5.3.2 Automotive Industry
5.3.3 Bottles manufacturing
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Bio-PET
6.2.2 PHA
6.2.3 Bio-PE
6.2.4 Starch Blends
6.2.5 PLA
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Packing Industry
6.3.2 Automotive Industry
6.3.3 Bottles manufacturing
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Bio-PET
7.2.2 PHA
7.2.3 Bio-PE
7.2.4 Starch Blends
7.2.5 PLA
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Packing Industry
7.3.2 Automotive Industry
7.3.3 Bottles manufacturing
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Bio-PET
8.2.2 PHA
8.2.3 Bio-PE
8.2.4 Starch Blends
8.2.5 PLA
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Packing Industry
8.3.2 Automotive Industry
8.3.3 Bottles manufacturing
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Bio-PET
9.2.2 PHA
9.2.3 Bio-PE
9.2.4 Starch Blends
9.2.5 PLA
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Packing Industry
9.3.2 Automotive Industry
9.3.3 Bottles manufacturing
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 NatureWorks
10.1.2 Braskem
10.1.3 BASF
10.1.4 Arkema
10.1.5 DuPont
10.1.6 Novamont
10.1.7 Corbion
10.1.8 Metabolix
10.1.9 PSM
10.1.10 PolyOne
10.1.11 Biome Bioplastics
10.1.12 Biomer
10.1.13 FKuR
10.1.14 Trellis Bioplastics
10.1.15 Kingfa
10.1.16 Cardia Bioplastics
10.1.17 Grabio
10.1.18 MHG
10.1.19 Myriant
10.1.20 Mitsubishi
10.1.21 Zhejiang Hisun Biomaterials
10.2 Biologics and Biosimilars Sales Date of Major Players (2017-2020e)
10.2.1 NatureWorks
10.2.2 Braskem
10.2.3 BASF
10.2.4 Arkema
10.2.5 DuPont
10.2.6 Novamont
10.2.7 Corbion
10.2.8 Metabolix
10.2.9 PSM
10.2.10 PolyOne
10.2.11 Biome Bioplastics
10.2.12 Biomer
10.2.13 FKuR
10.2.14 Trellis Bioplastics
10.2.15 Kingfa
10.2.16 Cardia Bioplastics
10.2.17 Grabio
10.2.18 MHG
10.2.19 Myriant
10.2.20 Mitsubishi
10.2.21 Zhejiang Hisun Biomaterials
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Biologics and Biosimilars Product Type Overview
2.Table Biologics and Biosimilars Product Type Market Share List
3.Table Biologics and Biosimilars Product Type of Major Players
4.Table Brief Introduction of NatureWorks
5.Table Brief Introduction of Braskem
6.Table Brief Introduction of BASF
7.Table Brief Introduction of Arkema
8.Table Brief Introduction of DuPont
9.Table Brief Introduction of Novamont
10.Table Brief Introduction of Corbion
11.Table Brief Introduction of Metabolix
12.Table Brief Introduction of PSM
13.Table Brief Introduction of PolyOne
14.Table Brief Introduction of Biome Bioplastics
15.Table Brief Introduction of Biomer
16.Table Brief Introduction of FKuR
17.Table Brief Introduction of Trellis Bioplastics
18.Table Brief Introduction of Kingfa
19.Table Brief Introduction of Cardia Bioplastics
20.Table Brief Introduction of Grabio
21.Table Brief Introduction of MHG
22.Table Brief Introduction of Myriant
23.Table Brief Introduction of Mitsubishi
24.Table Brief Introduction of Zhejiang Hisun Biomaterials
25.Table Products & Services of NatureWorks
26.Table Products & Services of Braskem
27.Table Products & Services of BASF
28.Table Products & Services of Arkema
29.Table Products & Services of DuPont
30.Table Products & Services of Novamont
31.Table Products & Services of Corbion
32.Table Products & Services of Metabolix
33.Table Products & Services of PSM
34.Table Products & Services of PolyOne
35.Table Products & Services of Biome Bioplastics
36.Table Products & Services of Biomer
37.Table Products & Services of FKuR
38.Table Products & Services of Trellis Bioplastics
39.Table Products & Services of Kingfa
40.Table Products & Services of Cardia Bioplastics
41.Table Products & Services of Grabio
42.Table Products & Services of MHG
43.Table Products & Services of Myriant
44.Table Products & Services of Mitsubishi
45.Table Products & Services of Zhejiang Hisun Biomaterials
46.Table Market Distribution of Major Players
47.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
48.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
49.Table Global Biologics and Biosimilars Market Forecast (Million USD) by Region 2021f-2026f
50.Table Global Biologics and Biosimilars Market Forecast (Million USD) Share by Region 2021f-2026f
51.Table Global Biologics and Biosimilars Market Forecast (Million USD) by Demand 2021f-2026f
52.Table Global Biologics and Biosimilars Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
